BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
59 results:

  • 1. Evaluating the Prognostic Factors and Survival Rates of Endometrial cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.
    Wannasin R; Thinkhamrop K; Kelly M; Likitdee N
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):671-679. PubMed ID: 38415555
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The use of fertility treatments among reproductive-aged women after cancer.
    Kipling LM; Shandley LM; Mertens AC; Spencer JB; Howards PP
    Fertil Steril; 2024 Apr; 121(4):578-588. PubMed ID: 38103881
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Histological and Genetic Diversity in ovarian Mucinous Carcinomas: A Pilot Study.
    Razia S; Nakayama K; Yamashita H; Ishibashi T; Ishikawa M; Kanno K; Sato S; Kyo S
    Curr Oncol; 2023 Apr; 30(4):4052-4059. PubMed ID: 37185420
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel therapeutics in low-grade serous ovarian cancer.
    Cobb L; Gershenson D
    Int J Gynecol Cancer; 2023 Mar; 33(3):377-384. PubMed ID: 36878564
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Erdheim-Chester Disease Involving the Left Uterine Adnexa: Mimicking an ovarian Carcinoma Clinically.
    Zeng Y; Wang Q; Wang X; Jiang X; Yao H; Tang X
    Int J Surg Pathol; 2023 Dec; 31(8):1532-1537. PubMed ID: 36855299
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy.
    ElNaggar A; Robins D; Baca Y; Arguello D; Ulm M; Arend R; Mantia-Smaldone G; Chu C; Winer I; Holloway R; Krivak T; Jones N; Galvan-Turner V; Herzog TJ; Brown J
    Gynecol Oncol; 2022 Nov; 167(2):306-313. PubMed ID: 36229265
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of Effectiveness as well as Advantages and Disadvantages of Different Dimensions of Hysterosalpingo-Contrast Sonography for diagnosis of Lesions Associated with Female Infertility.
    Pei R
    Comput Math Methods Med; 2022; 2022():7508880. PubMed ID: 36164612
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PRAME Expression in cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors.
    Kaczorowski M; Chłopek M; Kruczak A; Ryś J; Lasota J; Miettinen M
    Am J Surg Pathol; 2022 Nov; 46(11):1467-1476. PubMed ID: 35973038
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
    Musacchio L; Califano D; Bartoletti M; Arenare L; Lorusso D; Losito NS; Cormio G; Greggi S; Raspagliesi F; Valabrega G; Salutari V; Pisano C; Spina A; Russo D; Del Sesto M; Canzonieri V; Ferraù F; Zannoni GF; Loizzi V; Ghizzoni V; Casanova C; Tuninetti V; Ducceschi M; Del Vecchio V; Scalone S; Priolo D; Perrone F; Scambia G; Pignata S
    Br J Cancer; 2022 Nov; 127(8):1479-1486. PubMed ID: 35869143
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Low-grade serous carcinoma detected from intraoperative peritoneal washings: Cytological findings and detection of KRAS mutation.
    Yamamoto E; Warigaya K; Kinoshita Y; Yamamoto A; Murata SI
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1676. PubMed ID: 35801373
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes.
    Gershenson DM; Sun CC; Westin SN; Eyada M; Cobb LP; Nathan LC; Sood AK; Malpica A; Hillman RT; Wong KK
    Gynecol Oncol; 2022 Jun; 165(3):560-567. PubMed ID: 35606067
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metastatic Small Bowel Adenocarcinoma Mimicking a Primary ovarian Mucinous Tumour - Clinical, Radiologic, Pathologic and Molecular Correlation.
    Yang H; Yuan R; Alex D; Hughesman C; Liu S; Lee U; Zhou C; Wang G
    Int J Surg Pathol; 2023 Feb; 31(1):110-118. PubMed ID: 35477328
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous ovarian Carcinoma.
    Manning-Geist B; Gordhandas S; Liu YL; Zhou Q; Iasonos A; Da Cruz Paula A; Mandelker D; Long Roche K; Zivanovic O; Maio A; Kemel Y; Chi DS; O'Cearbhaill RE; Aghajanian C; Weigelt B; Chui MH; Grisham RN
    Clin Cancer Res; 2022 Oct; 28(20):4456-4465. PubMed ID: 35443055
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ovarian cancer Detection in Average-Risk Women: Classic- versus Nonclassic-appearing Adnexal Lesions at US.
    Gupta A; Jha P; Baran TM; Maturen KE; Patel-Lippmann K; Zafar HM; Kamaya A; Antil N; Barroilhet L; Sadowski E
    Radiology; 2022 Jun; 303(3):603-610. PubMed ID: 35315722
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. An ultrasensitive biosensor for dual-specific DNA based on deposition of polyaniline on a self-assembled multi-functional DNA hexahedral-nanostructure.
    Chen H; Xiang Y; Cai R; Zhang L; Zhang Y; Zhou N
    Biosens Bioelectron; 2021 May; 179():113066. PubMed ID: 33571935
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary ovarian Melanoma Arising From a Mature Teratoma With Melanoma In Situ Present in the Ciliated Columnar and Squamous Epithelium in a Patient With Synchronous Skin Basal Cell Carcinoma.
    Lai J; Garvey KY; Li P; Azevedo RA
    Int J Gynecol Pathol; 2021 Jul; 40(4):383-390. PubMed ID: 33560745
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Case of Paratubal Serous Borderline Tumor Driven by a Somatic braf Mutation in an Adolescent Patient.
    Chao A; Huang YL; Lin CY; Chao AS; Lee YS; Wu RC; Lai CH
    J Pediatr Adolesc Gynecol; 2021 Apr; 34(2):228-230. PubMed ID: 33188936
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Population-based estimates of survival among elderly patients with brain metastases.
    Lamba N; Kearney RB; Catalano PJ; Hassett MJ; Wen PY; Haas-Kogan DA; Aizer AA
    Neuro Oncol; 2021 Apr; 23(4):661-676. PubMed ID: 33068418
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.
    Valiakhmetova A; Gorelyshev S; Konovalov A; Trunin Y; Savateev A; Kram DE; Severson E; Hemmerich A; Edgerly C; Duncan D; Britt N; Huang RSP; Elvin J; Miller V; Ross JS; Gay L; McCorkle J; Rankin A; Erlich RL; Chudnovsky Y; Ramkissoon SH
    Oncologist; 2020 Feb; 25(2):e198-e202. PubMed ID: 32043779
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Black Women's Confidence in the Genetic Information Nondiscrimination Act.
    Sutton AL; Henderson A; Hurtado-de-Mendoza A; Tanner E; Khan M; Quillin J; Sheppard VB
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31847347
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.